Cite
Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade
MLA
Eisuke Tatsumi, et al. “Azilsartan Ameliorates Diabetic Cardiomyopathy in Young Db/Db Mice through the Modulation of ACE-2/ANG 1-7/Mas Receptor Cascade.” Biochemical Pharmacology, vol. 144, May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7380cee499a3f3b5a824a6275dfb34f6&authtype=sso&custid=ns315887.
APA
Eisuke Tatsumi, Mikiyasu Shirai, James T. Pearson, Hirotsugu Tsuchimochi, & Vijayakumar Sukumaran. (2017). Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade. Biochemical Pharmacology, 144.
Chicago
Eisuke Tatsumi, Mikiyasu Shirai, James T. Pearson, Hirotsugu Tsuchimochi, and Vijayakumar Sukumaran. 2017. “Azilsartan Ameliorates Diabetic Cardiomyopathy in Young Db/Db Mice through the Modulation of ACE-2/ANG 1-7/Mas Receptor Cascade.” Biochemical Pharmacology 144 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7380cee499a3f3b5a824a6275dfb34f6&authtype=sso&custid=ns315887.